Sigal Sviri

492 total citations
23 papers, 301 citations indexed

About

Sigal Sviri is a scholar working on Epidemiology, Immunology and Surgery. According to data from OpenAlex, Sigal Sviri has authored 23 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Immunology and 4 papers in Surgery. Recurrent topics in Sigal Sviri's work include Sepsis Diagnosis and Treatment (3 papers), Respiratory Support and Mechanisms (2 papers) and Tracheal and airway disorders (2 papers). Sigal Sviri is often cited by papers focused on Sepsis Diagnosis and Treatment (3 papers), Respiratory Support and Mechanisms (2 papers) and Tracheal and airway disorders (2 papers). Sigal Sviri collaborates with scholars based in Israel, Australia and United States. Sigal Sviri's co-authors include Peter Vernon van Heerden, David M. Linton, Chen-Fuh Lam, Kenneth F. Ilett, Michal Shapira, Allon E. Moses, Dana G. Wolf, Tawfik Khoury, Sara El Hoss and Ran Nir‐Paz and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Sigal Sviri

21 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sigal Sviri Israel 10 99 51 43 43 34 23 301
Halıt Çam Türkiye 11 80 0.8× 42 0.8× 36 0.8× 75 1.7× 52 1.5× 42 368
Annie Robert Belgium 12 112 1.1× 65 1.3× 103 2.4× 37 0.9× 20 0.6× 23 454
Mary Lynne Weemering 5 116 1.2× 70 1.4× 40 0.9× 28 0.7× 44 1.3× 7 344
Jan-Sören Padberg Germany 9 66 0.7× 35 0.7× 46 1.1× 44 1.0× 19 0.6× 15 320
Konstantinos Kollios Greece 13 112 1.1× 69 1.4× 53 1.2× 15 0.3× 13 0.4× 36 399
Marie‐Louise Trotman United States 7 51 0.5× 72 1.4× 34 0.8× 71 1.7× 55 1.6× 16 380
Todd Karsies United States 9 131 1.3× 65 1.3× 86 2.0× 68 1.6× 17 0.5× 32 410
Xiaobo Huang China 12 93 0.9× 75 1.5× 50 1.2× 49 1.1× 20 0.6× 33 380
Corina Nailescu United States 8 75 0.8× 52 1.0× 47 1.1× 38 0.9× 64 1.9× 22 321
R M Chichmanian France 12 88 0.9× 94 1.8× 49 1.1× 96 2.2× 22 0.6× 53 498

Countries citing papers authored by Sigal Sviri

Since Specialization
Citations

This map shows the geographic impact of Sigal Sviri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sigal Sviri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sigal Sviri more than expected).

Fields of papers citing papers by Sigal Sviri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sigal Sviri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sigal Sviri. The network helps show where Sigal Sviri may publish in the future.

Co-authorship network of co-authors of Sigal Sviri

This figure shows the co-authorship network connecting the top 25 collaborators of Sigal Sviri. A scholar is included among the top collaborators of Sigal Sviri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sigal Sviri. Sigal Sviri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Korem, Maya, Efrat Orenbuch‐Harroch, Matan J. Cohen, et al.. (2025). Risk factors associated with cytomegalovirus reactivation and disease in critically-ill COVID-19 and non-COVID-19 patients, concomitantly admitted to intensive care. Scientific Reports. 15(1). 41840–41840.
2.
Heerden, Peter Vernon van, et al.. (2021). Apoptotic Cells for Therapeutic Use in Cytokine Storm Associated With Sepsis– A Phase Ib Clinical Trial. Frontiers in Immunology. 12. 718191–718191. 14 indexed citations
4.
Trahtemberg, Uriel, et al.. (2019). Cytokine patterns in critically ill patients undergoing percutaneous tracheostomy. Clinical & Experimental Immunology. 198(1). 121–129.
5.
Gesser‐Edelsburg, Anat, Peter Vernon van Heerden, Sigal Sviri, et al.. (2018). Beyond the hospital infection control guidelines: a qualitative study using positive deviance to characterize gray areas and to achieve efficacy and clarity in the prevention of healthcare-associated infections. Antimicrobial Resistance and Infection Control. 7(1). 124–124. 18 indexed citations
6.
Sviri, Sigal, et al.. (2016). The Role of Vitamin B12 in the Critically Ill—a Review. Anaesthesia and Intensive Care. 44(4). 447–452. 47 indexed citations
7.
Khoury, Tawfik, Sigal Sviri, Sara El Hoss, et al.. (2016). Increased rates of intensive care unit admission in patients with Mycoplasma pneumoniae : a retrospective study. Clinical Microbiology and Infection. 22(8). 711–714. 40 indexed citations
8.
Sviri, Sigal, et al.. (2013). Does high-dose vasopressor therapy in medical intensive care patients indicate what we already suspect?. Journal of Critical Care. 29(1). 157–160. 34 indexed citations
9.
Ganz, Freda DeKeyser, et al.. (2012). The legal guardians' dilemma: Decision making associated with invasive non-life-saving procedures. Israel Journal of Health Policy Research. 1(1). 36–36. 4 indexed citations
10.
Elias, Shlomo, Sigal Sviri, Efrat Orenbuch‐Harroch, et al.. (2011). Sildenafil to Facilitate Weaning From Inhaled Nitric Oxide and Mechanical Ventilation in a Patient With Severe Secondary Pulmonary Hypertension and a Patent Foramen Ovale. Respiratory Care. 56(10). 1611–1613. 7 indexed citations
11.
Sviri, Sigal, Yaakov Garb, Alan Rubinow, et al.. (2009). Contradictions in end-of-life decisions for self and other, expressed by relatives of chronically ventilated patients. Journal of Critical Care. 24(2). 293–301. 15 indexed citations
12.
Wolf, Dana G., Gail Amir, Batia Avni, et al.. (2007). Severe Epstein–Barr virus-associated hemophagocytic syndrome in six adult patients. Journal of Clinical Virology. 40(2). 156–159. 21 indexed citations
13.
Cohen‐Poradosu, Ronit, et al.. (2007). Thoracic actinomycosis with extension of the infection to the pericardium and chest wall.. PubMed. 9(6). 490–1. 2 indexed citations
14.
Sviri, Sigal, et al.. (2003). Long-term Outcomes following Percutaneous Tracheostomy Using the Griggs Technique. Anaesthesia and Intensive Care. 31(4). 401–407. 9 indexed citations
15.
Heerden, Peter Vernon van, Sigal Sviri, Kenneth F. Ilett, & Chen-Fuh Lam. (2002). Inhaled diazeniumdiolates (NONOates) as selective pulmonary vasodilators. Expert Opinion on Investigational Drugs. 11(7). 897–909. 29 indexed citations
16.
Sviri, Sigal, et al.. (2001). Plasmapheresis for Thrombotic Thrombocytopenic Purpura following Bone Marrow Transplantation. Acta Haematologica. 105(3). 156–158. 6 indexed citations
17.
Muszkat, Mordechai, Michal Shapira, Sigal Sviri, David M. Linton, & Yoseph Caraco. (1998). Ticlopidine‐Induced Thrombotic Thrombocytopenic Purpura. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(6). 1352–1355. 15 indexed citations
18.
Shapira, Michal, Yosef S. Haviv, & Sigal Sviri. (1998). Second degree atrio-ventricular block and cardiotoxicity secondary to envenomation by the scorpion Leiurus quinquestriatus (`Yellow Scorpion') - an indication for serotherapy?. Human & Experimental Toxicology. 17(10). 541–543. 8 indexed citations
19.
Sviri, Sigal, David Raveh, I Boldur, et al.. (1997). Legionella feeleii pneumonia and pericarditis. Journal of Infection. 34(3). 277–279. 6 indexed citations
20.
Levy, Micha, Ester Zylber‐Katz, Yaron Ilan, et al.. (1997). Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis B virus*. Clinical Pharmacology & Therapeutics. 62(1). 6–14. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026